In the announcement, FDA Commissioner Mackary said, “Bayesian methodologies help address two of the biggest problems of drug ...
Cravings affect addiction recovery and relapse. Treatment must help the person with substance use disorder relearn healthy risk vs. benefit analyses and behaviors to overwrite old reflexes.